Sales rise 35.81% to Rs 526.31 crore
Net profit of Astrazeneca Pharma India reported to Rs 55.83 crore in the quarter ended June 2025 as against net loss of Rs 11.79 crore during the previous quarter ended June 2024. Sales rose 35.81% to Rs 526.31 crore in the quarter ended June 2025 as against Rs 387.52 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales526.31387.52 36 OPM %15.419.82 -PBDT91.6346.31 98 PBT75.0642.40 77 NP55.83-11.79 LPPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
